These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 21874645

  • 1. Conservative management of placenta increta: case report and literature review.
    Yarandi F, Eftekhar Z, Shojaei H, Rahimi-Sharbaf F, Baradaran F.
    Acta Med Iran; 2011; 49(6):396-8. PubMed ID: 21874645
    [Abstract] [Full Text] [Related]

  • 2. Partial placenta increta and methotrexate therapy: three case reports.
    Pinho S, Sarzedas S, Pedroso S, Santos A, Rebordão M, Avillez T, Casal E, Hermida M.
    Clin Exp Obstet Gynecol; 2008; 35(3):221-4. PubMed ID: 18754299
    [Abstract] [Full Text] [Related]

  • 3. Conservative treatment of placenta increta with methotrexate.
    Crespo R, Lapresta M, Madani B.
    Int J Gynaecol Obstet; 2005 Nov; 91(2):162-3. PubMed ID: 16126207
    [No Abstract] [Full Text] [Related]

  • 4. Placenta increta; conservative management -- a successful outcome. Case report and literature review.
    Adair SR, Elamin D, Tharmaratnam S.
    J Matern Fetal Neonatal Med; 2004 Apr; 15(4):275-8. PubMed ID: 15280137
    [Abstract] [Full Text] [Related]

  • 5. Human placental lactogen and color Doppler in predicting expulsion of retained adherent placenta: a new clinical observation.
    Zepiridis L, Zafrakas M, Theodoridis TD, Assimakopoulos E, Tzevelekis P, Athanatos D, Bontis JN, Tarlatzis BC.
    Arch Gynecol Obstet; 2009 Dec; 280(6):1041-4. PubMed ID: 19333613
    [Abstract] [Full Text] [Related]

  • 6. Magnetic resonance imagining (MRI) and serial beta-human chorionic gonadotrophin (beta-hCG) follow up for placenta percreta.
    El-Bialy G, Kassab A, Armstrong M.
    Arch Gynecol Obstet; 2007 Oct; 276(4):371-3. PubMed ID: 17356825
    [Abstract] [Full Text] [Related]

  • 7. Retrospective analysis: Conservative treatment of placenta increta with methotrexate.
    Zhang C, Li H, Zuo C, Wang X.
    J Obstet Gynaecol Res; 2018 May; 44(5):907-913. PubMed ID: 29484784
    [Abstract] [Full Text] [Related]

  • 8. Placenta percreta: methotrexate treatment and MRI findings.
    Heiskanen N, Kröger J, Kainulainen S, Heinonen S.
    Am J Perinatol; 2008 Feb; 25(2):91-2. PubMed ID: 18176907
    [Abstract] [Full Text] [Related]

  • 9. Placenta increta: Use of dynamic MRI for diagnosis and evaluation of placental vascularity.
    Honnma H, Endo T, Hayashi T, Saito T.
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):131-3. PubMed ID: 16962230
    [No Abstract] [Full Text] [Related]

  • 10. Postpartum monitoring of retained placenta.Two cases of abnormally adherent placenta.
    Torrenga B, Huirne JA, Bolte AC, van Waesberghe JH, de Vries JI.
    Acta Obstet Gynecol Scand; 2013 Apr; 92(4):472-5. PubMed ID: 22731843
    [Abstract] [Full Text] [Related]

  • 11. Conservative management of live tubal pregnancies by ultrasound guided potassium chloride injection and systemic methotrexate treatment.
    Verma U, Jacques E.
    J Clin Ultrasound; 2005 Dec; 33(9):460-3. PubMed ID: 16281271
    [Abstract] [Full Text] [Related]

  • 12. [Case report: seventeen year old primipara with placenta increta, treated with methotrexate].
    Arnadottir BT, Hardardóttir H, Marvinsdóttir B.
    Laeknabladid; 2008 Jul; 94(7-8):549-52. PubMed ID: 18591730
    [Abstract] [Full Text] [Related]

  • 13. The use of serial betaHCG to plan surgical evacuation of retained placenta in a case of placenta accreta.
    Kulkarni A, Draycott T.
    J Matern Fetal Neonatal Med; 2005 Apr; 17(4):295-7. PubMed ID: 16147840
    [Abstract] [Full Text] [Related]

  • 14. Utility of the pulsatility index of the uterine arteries and human chorionic gonadotropin in a series of cases of placenta accreta.
    Dueñas-Garcia OF, Diaz-Sotomayor M, Rico-Olvera H.
    J Obstet Gynaecol Res; 2011 Aug; 37(8):1112-6. PubMed ID: 21463424
    [Abstract] [Full Text] [Related]

  • 15. Successful treatment of Placenta Percreta through a combinatorial treatment involving a Bakri Balloon and Methotrexate--a case report.
    Akdemir N, Cevrioğlu AS, Özden S, Gündüz Y, Ilhan G.
    Ginekol Pol; 2015 Aug; 86(8):631-4. PubMed ID: 26492714
    [Abstract] [Full Text] [Related]

  • 16. [Clinical efficacy and safety of uterine artery chemoembolization in abnormal placental implantation complicated with postpartum hemorrhage].
    Chen YT, Xu LF, Sun HL, Li HQ, Hu RM, Tan QY.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):273-7. PubMed ID: 20646539
    [Abstract] [Full Text] [Related]

  • 17. Conservative management of morbidly adherant placenta - a case report and review of literature.
    Khan M, Sachdeva P, Arora R, Bhasin S.
    Placenta; 2013 Oct; 34(10):963-6. PubMed ID: 23937959
    [Abstract] [Full Text] [Related]

  • 18. Methotrexate management for placenta accreta: a prospective study.
    Lin K, Qin J, Xu K, Hu W, Lin J.
    Arch Gynecol Obstet; 2015 Jun; 291(6):1259-64. PubMed ID: 25501835
    [Abstract] [Full Text] [Related]

  • 19. Serum β-hCG levels post-treatment of ectopic pregnancy with a single dose of intramuscular methotrexate.
    Hadinata IE, Doyle LW, Thompson D, Reti L.
    Aust N Z J Obstet Gynaecol; 2015 Apr; 55(2):181-4. PubMed ID: 25898911
    [Abstract] [Full Text] [Related]

  • 20. Maternal plasma levels of cell-free β-HCG mRNA as a prenatal diagnostic indicator of placenta accrete.
    Zhou J, Li J, Yan P, Ye YH, Peng W, Wang S, Wang XT.
    Placenta; 2014 Sep; 35(9):691-5. PubMed ID: 25063251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.